Compare Apple Inc (AAPL) vs HCA Health Inc (HCA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Apple Inc vs HCA Health Inc — how do they compare? Apple Inc trades at $306.11 (market cap $4.50T), while HCA Health Inc trades at $410.71 (market cap $89.64B). The key difference: Apple Inc is far larger — about 50.2× HCA Health Inc's market cap, and HCA Health Inc pays the higher dividend (0.75%). Which is the better fit depends on your goals.
| AAPL | HCA | |
|---|---|---|
Market Cap | $4.50T | $89.64B |
Volume | 100,358,844 | — |
Sector | Technology | Health |
52-Week High | $340.08 | $545.13 |
52-Week Low | $224.90 | $361.32 |
Enterprise Value | $4.52T | $140.18B |
Dividend Yield | 0.35% | 0.75% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AAPL trades at $307.24, down 1.94% over the past day, with technical indicators signaling a bearish trend. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $2.02 exceeding the $1.89 estimate. Revenue grew to $416.16B in 2025, and net income margin improved to 27.62%. Recent news highlights Apple's leadership in smartphone shipments and AI potential through its 2.5 billion active devices.
The outlook remains positive with a consensus price target of $337.63, implying upside, supported by robust cash flow and profitability. Risks include potential earnings misses, union disputes, and regulatory fines. Analyst sentiment is bullish with 63.64% buy ratings, but technical weakness and competitive pressures warrant caution.
HCA Healthcare trades at $413.36, up 1.09% on the day, with a bullish technical outlook supported by moving averages and a consensus analyst price target of $449.93. The company reported strong Q2 2026 earnings of $7.59 per share, beating estimates, and has shown consistent revenue growth, reaching $75.60 billion in 2025. Recent corporate actions include dividend payments of $0.78 per share, while news highlights executive appointments and ongoing legal investigations.
The stock presents a compelling investment case with attractive valuation multiples like a P/E of 13.86 and robust profitability, but faces risks from legal probes and high debt levels. Upside potential is supported by analyst optimism and solid operational cash flow, though investors should monitor expense pressures and regulatory developments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Apple Inc
Apple Inc. designs, manufactures, and markets personal computers and related personal computing and mobile communication devices along with a variety of related software, services, peripherals, and networking solutions. Apple sells its products worldwide through its online stores, its retail stores, its direct sales force, third-party wholesalers, and resellers.
Read more on AAPL →About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →
